EDGE
  • home.svg
    Home
  • news.svg
    All updates
  • news.svg
    EDGE Insights
  • list.svg
    Industries
  • db-search.svg
    Company Search
  • company-list.svg
    My Watchlists (Beta)
All Updates

All Updates

icon
Filter
Partnerships
Fluence partners with Metamorph AI to develop GenAI tool for psychedelic therapy training
Psychedelic Medicine
May 21, 2024
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
‧
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Psychedelic Medicine

Psychedelic Medicine

View industry hub
May 21, 2024

Fluence partners with Metamorph AI to develop GenAI tool for psychedelic therapy training

Partnerships

  • Fluence, a company specializing in psychedelic therapy training, has partnered with Metamorph AI, a technology company, to develop a GenAI tool for psychedelic therapy training.

  • The tool analyzes therapist role-play sessions, identifies areas for improvement, and provides actionable feedback by highlighting missed therapeutic opportunities, flagging deeper engagement possibilities, and generating self-assessment reports. It's integrated into Fluence’s training program to boost training efficiency, and therapy effectiveness while reducing review time for instructors.

  • Analyst QuickTake: Fluence has established several partnerships within the psychedelic industry, including Reunion Neuroscience (April 2024), Psyence (April 2024), Cybin (September 2023), and Tryp Therapeutics (May 2021). The latest partnership with Metamorph AI is expected to enhance the landscape of psychedelic therapy training.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.